White Paper

Making AI Usable For Pharma and Biopharma

AI

Artificial intelligence (AI) is already making a huge contribution to the global economy, even though this development is still in its early stages. AI is a kind of turbo drive for the new digital technologies, because it enables machines to imitate human decision-making processes.

Currently, AI is revolutionizing the healthcare system, where AI-based software is increasingly becoming a part of medical procedures. Robots are providing assistance during operations, while wearables are measuring every pulse beat and transmitting the data to doctors. Moreover, researchers are developing AI that can recognize cardiovascular and blood diseases. Already today, visual scans are used for remote medical screenings.

This development is also opening up great opportunities for pharmaceutical and biotech companies, because AI is useful not only for smart medical solutions but also for the pharmaceutical development and production. In the future, software solutions that include AI are expected to help discover and exploit optimization potential that is hidden today, thus maximizing the yield of a pharmaceutical product or reducing production costs, for example.

This white paper explores how to use artificial intelligence to uncover hidden business value in the regulated pharmaceutical and biotech industries.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

Werum IT Solutions America, Inc.